Understanding Natural Killer Cell Development and Target Recognition [ 2012 - 2015 ]

Research Grant

Researchers: Dr Daniel Andrews (Principal investigator)

Brief description Immune detection and eradication or control of cancer and cancer immunotherapies are based in part on the idea that tumour-specific white blood cells can protect the body from tumour development, growth and metastases. While strong evidence supports this, the means by which these white cells first recognize the cancerous tissue is largely unknown. We will study a new family of white blood cell receptors that may be important in this recognition, either naturally or following therapy.

Funding Amount $AUD 408,388.01

Funding Scheme Career Development Fellowships

Notes RD Wright Biomedical CDF